Clinical Trial Update: NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. [NA]

View source ↗

Summary

A clinical trial update shows the NWRD09 therapy is currently recruiting for HPV-16 positive cervical intraepithelial neoplasia and cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• NWRD09

Snippet

Sponsor: Newish Technology (Beijing) Co., Ltd. | Conditions: Intraepithelial Neoplasia, Cervical Cancer | NA | Status: RECRUITING